| Drug Type Small molecule drug | 
| Synonyms milk derived peptides (Lactocore) | 
| Target | 
| Action modulators | 
| Mechanism CACNA2D1 modulators(Voltage-gated calcium channel alpha2/delta subunit 1 modulators) | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Behavioural disorders | Preclinical | United States  | - | |
| Cognition Disorders | Preclinical | United States  | - | |
| Metabolic Diseases | Preclinical | United States  | - | 





